Clinical Trial

The EEG Study Under Remimazolam Anesthesia in Children

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 6, 2025 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The effect of Remimazolam on brain electrical activity. Previous studies have shown that in healthy male volunteers, EEG changes during Remimazolam infusion are characterized by an initial increase in the beta band and a later increase in the delta band. When monitoring the depth of anesthesia, the commonly used Bispectral Index in clinical practice was originally developed for propofol. Therefore, studies have shown that the correlation between the depth of sedation of benzodiazepines such as midazolam and Bispectral Index is weak. In contrast, the beta wave ratio is considered a more suitable EEG indicator for monitoring the sedative effect of Remimazolam. The above indicates that Remimazolam has a specific pattern of influence on EEG activity, especially in the regulation of anesthesia depth, with unique characteristics.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-11-20.
Status change: Not Yet Recruiting → Recruiting 2025-02-04
Trial Details
NCT Number NCT06698705
Lead Sponsor Second Affiliated Hospital of Wenzhou Medical University
Conditions Electroencephalography, Remimazolam, Child Neglect
Enrollment 60 participants
Start Date 2024-11-22
Primary Completion 2025-12-01 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-02-06